JPH01274066A - Enzyme immunoassay method - Google Patents
Enzyme immunoassay methodInfo
- Publication number
- JPH01274066A JPH01274066A JP10321788A JP10321788A JPH01274066A JP H01274066 A JPH01274066 A JP H01274066A JP 10321788 A JP10321788 A JP 10321788A JP 10321788 A JP10321788 A JP 10321788A JP H01274066 A JPH01274066 A JP H01274066A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- microplate
- film
- membrane
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 13
- 238000003018 immunoassay Methods 0.000 title claims abstract description 13
- 239000000427 antigen Substances 0.000 claims abstract description 13
- 102000036639 antigens Human genes 0.000 claims abstract description 13
- 108091007433 antigens Proteins 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000013566 allergen Substances 0.000 claims abstract description 10
- 230000003287 optical effect Effects 0.000 claims abstract description 7
- 239000012528 membrane Substances 0.000 claims description 39
- 206010020751 Hypersensitivity Diseases 0.000 claims description 2
- 208000026935 allergic disease Diseases 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- 238000005259 measurement Methods 0.000 abstract description 13
- 238000004140 cleaning Methods 0.000 abstract description 7
- 238000006911 enzymatic reaction Methods 0.000 abstract description 4
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 238000013208 measuring procedure Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 229960004784 allergens Drugs 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 241000238876 Acari Species 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 241000218645 Cedrus Species 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229940074608 allergen extract Drugs 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229940046552 various allergen extract Drugs 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- -1 antiserum Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
本発明はマイクロプレートを用いた酵素免疫測定法にお
いて、マイクロプレートのウェル(穴)に、抗原または
抗体を固定し中央部が空洞となっている膜を挿入し、そ
れを取り出すことなく光学装置によって検体濃度を測定
する方法に関する。Detailed Description of the Invention The present invention is an enzyme immunoassay method using a microplate, in which a membrane having an antigen or antibody immobilized thereon and having a hollow center is inserted into a well (hole) of a microplate. The present invention relates to a method for measuring the concentration of an analyte using an optical device without taking out the sample.
酵素免疫測定、蛍光免疫測定及び発光免疫測定等の免疫
学的な分析方法において、不溶坦体としてポリスチレン
ボール、ガラスピーズ、ろ紙またはニトロセルロース等
に抗原または抗体を共役結合または非化学的に同定し測
定する方法がある。In immunological analysis methods such as enzyme immunoassay, fluorescence immunoassay, and luminescent immunoassay, antigens or antibodies are conjugated or non-chemically identified to insoluble carriers such as polystyrene balls, glass beads, filter paper, or nitrocellulose. There is a way to measure it.
その際1反応槽としてマイクロプレートウェルを利用し
ている場合は、それらの担体を取り出すかまたは測定液
を別の容器に移した後、酵素反応によって生じる発色、
蛍光等を分光ソC学的に計測する必要がある。If a microplate well is used as one reaction tank, after removing the carrier or transferring the measurement solution to another container, the color development caused by the enzyme reaction,
It is necessary to measure fluorescence etc. spectroscopically.
また、不溶坦体を除去しないで測定できる方法としては
、マイクロプレートのウェルの壁面に。Another method that allows measurement without removing the insoluble carrier is to place it on the wall of the well of a microplate.
直接、抗原または抗体を共役結合または非化学的に固定
することにより、担体を除去する等の操作を必要とせず
5そのまま酵素反応によって生じる発色、蛍光または発
光を分光光学的に計測する方法も知られている。There is also a method of spectrophotometrically measuring the color, fluorescence, or luminescence generated by an enzymatic reaction without requiring any operations such as removing the carrier by directly immobilizing the antigen or antibody through a covalent bond or non-chemically. It is being
ところで、マイクロプレートのウェル、ポリスチレンボ
ール及びガラスピーズの表面積は大変小さく、有効表面
積もその数倍から数1−倍であるため、抗原または抗体
の結合敬に依存する8[す定感度を増し難いという問題
があった。By the way, the surface area of microplate wells, polystyrene balls, and glass beads is very small, and the effective surface area is several to several times larger, so it is difficult to increase the sensitivity, which depends on the antigen or antibody binding. There was a problem.
一方、有効表面積が数百倍である濾紙、ニトロセルロー
ス、ナイロン繊維膜及びフッ素繊維膜は取り出し等の取
り扱いが難しく、さらにこれらの膜素材は、不透明なの
で光が通過せず、マイクロプレート吸光度読取装置にそ
のまま挿入して計洞することができない。また、洗浄時
に膜が壁面に密着してしまい、膜の表面が洗浄しにくい
という問題がある。洗浄は持ち込み反応等のブランク反
応?少なくするためにIfl、要な工程であり、収形態
は洗浄効果に大きく影響してくる。On the other hand, filter paper, nitrocellulose, nylon fiber membranes, and fluorine fiber membranes, which have an effective surface area several hundred times larger, are difficult to remove and handle, and furthermore, these membrane materials are opaque and do not allow light to pass through, making them difficult to use with microplate absorbance reading devices. It is not possible to insert it as is and measure it. Another problem is that the membrane adheres to the wall surface during cleaning, making it difficult to clean the surface of the membrane. Is cleaning a blank reaction such as carry-on reaction? It is an important step to reduce Ifl, and the form of collection greatly affects the cleaning effect.
そこで、タンパク質を共有結合させられる機能を有する
膜を1表面を汚すことなくマイクロプレートのウェルの
底面と相似JFeに裁断し、更に中央部を切りぬいて空
洞とし、そしてこの膜に抗原又は抗体を結合させて被検
血清と反応させたのち酵素!32抗体液を注入し酵素免
疫反応をおこなうことにより、従来の問題点が解決でき
ることを見い出し、本発明をブこ成した。Therefore, we cut a membrane that has the function of covalently bonding proteins into a JFe similar to the bottom of the wells of a microplate without contaminating the surface, cut out the center part to make a cavity, and then applied antigens or antibodies to this membrane. After binding and reacting with the test serum, the enzyme! It was discovered that the conventional problems could be solved by injecting No. 32 antibody solution and performing an enzyme immunoreaction, and the present invention was accomplished.
すなわち、本発明は、マイクロプレートを用いた酵素免
疫測定法において、マイクロプレートのウェルに抗1g
または抗体が固定され中央部が空洞となっている膜を入
れ、光学装置によって検体濃度を測定する方法に関する
。That is, the present invention provides an enzyme immunoassay method using a microplate, in which anti-1g is added to the wells of the microplate.
Alternatively, the present invention relates to a method in which a membrane in which an antibody is immobilized and a hollow center is inserted and the concentration of a sample is measured using an optical device.
本発明で用いられるマイクロプレートとしては市販され
ているものをそのまま用いてもよい。As the microplate used in the present invention, commercially available microplates may be used as they are.
但し、その底面は光を透過するもので、好ましくは、透
明でかつ・■滑なものがよい。However, the bottom surface should be transparent and preferably transparent and smooth.
膜の形状については、マイクロプレートのウェルの底面
の形状と同一のものが好ましく、大きさは1例えば、ウ
ェルが円筒形の場合は、膜の直径がウェルの直径の0.
70〜0.95倍のものが好ましい。 そして、その
材質は、特に限定されないが、例えば、ナイロン膜、フ
ッ素樹脂膜、ろ紙、ニトロセルロース膜等があり、表面
積を大きくするため繊維質から成るものすなわちナイロ
ン繊維膜、フッ素繊維膜等がより好ましい。 上記の
膜の中央部には、空洞があり、その膜の形状は、測定時
に光路をさまたげないものであれば、特に限定されない
が、好ましくは円形状のものがよい。 例えば、ウェル
の直径7mmで、股の直径が6mmの場合、空洞の直径
は、 2.5〜;3゜5 m mが、好ましい。The shape of the membrane is preferably the same as the shape of the bottom of the well of the microplate, and the size is 1. For example, if the well is cylindrical, the diameter of the membrane is 0.0 mm of the diameter of the well.
70 to 0.95 times is preferable. The material is not particularly limited, but examples include nylon membranes, fluororesin membranes, filter paper, nitrocellulose membranes, etc. In order to increase the surface area, fibrous membranes, such as nylon fiber membranes and fluorine fiber membranes, are more preferred. preferable. There is a cavity in the center of the above membrane, and the shape of the membrane is not particularly limited as long as it does not obstruct the optical path during measurement, but is preferably circular. For example, when the diameter of the well is 7 mm and the diameter of the crotch is 6 mm, the diameter of the cavity is preferably 2.5 to 3.5 mm.
膜に固定する抗原または抗体としては1例えばダニ、ハ
ウスデス1−1花粉類、卵白、ミルク、大α、カビ、動
物の毛等のアレルゲン; 抗血清;黄体ホルモン、イン
シュリン等のホルモン;A I DS、ΔT I、 、
肝炎、ヘルペス等のウィルス抗体; HI、 A等の白
血球表面抗体;前立腺酸性ホスホツーゼ等の酵素などが
あり、好ましくは、アレルゲンを結合させたものが適し
ている。Antigens or antibodies to be fixed on the membrane include 1. Allergens such as mites, house death 1-1 pollen, egg white, milk, α-α, mold, and animal hair; Antiserum; Hormones such as progesterone and insulin; A.I. DS, ΔT I, ,
Antibodies to viruses such as hepatitis and herpes; leukocyte surface antibodies such as HI and A; and enzymes such as prostatic acid phosphodase. Preferably, those bound to allergens are suitable.
測定方法に関しては、通常用いられる酵素免疫測定、発
光免疫測定、蛍光免疫洞室等が用いられる。As for the measurement method, commonly used enzyme immunoassays, luminescent immunoassays, fluorescence immunosinus chambers, etc. are used.
また、光学装置については、市販されているマイクロプ
レートリーダ等を用いればよい。Furthermore, as for the optical device, a commercially available microplate reader or the like may be used.
本発明方法を用いた場合の副室′f−順は、例えば以下
のとおりである。For example, the order of subchambers'f when using the method of the present invention is as follows.
(1)マイクロプレートのウェルに膜を揮人(2)抗原
または抗体を含む体液等の検体を注入(3)洗浄
(4)標識抗体を入れる
(5)洗浄
(6)酵素反応
(7)光学装置による固定
本発明方法は、膜に固定する抗原又は抗体の種類を変え
ることによりアレルゲン、抗血清、ホルモン、酵素、ウ
ィルス抗体、白血球表面抗体等の体液中の微量蛋白など
の検出方法に適している。(1) Transfer the membrane to the wells of the microplate (2) Inject the sample such as body fluid containing antigen or antibody (3) Wash (4) Add the labeled antibody (5) Wash (6) Enzyme reaction (7) Optical Immobilization using a device The method of the present invention is suitable for detecting trace amounts of proteins in body fluids such as allergens, antiserum, hormones, enzymes, virus antibodies, and white blood cell surface antibodies by changing the type of antigen or antibody to be immobilized on the membrane. There is.
またモノクローナル抗体のスクリーニングにも応用でき
る。It can also be applied to screening monoclonal antibodies.
以E、本発明方法によれば、膜の中央部を空洞にするこ
とによって光が透過するようになり、痕がウェルの底に
あってもマイクロプレート吸光度読取装置にそのまま挿
入しての測定が可能となりまた、洗浄液、反応液または
検体の注入によって膜が舞い上がり、膜の裏面にまで液
が十分に行きわたるので、バラツキの少ない測定が可能
となった、 すなわち、洗浄時及び測定時に膜を取り出
す必要がないので、操作時間が大幅にIi縮されしかも
81ツ定の際、膜の有無にかかわらず測定値に差がなく
正確な測定ができ、従来の方法に比してより優れた酵素
免疫測定方法であるといえる。According to the method of the present invention, light can pass through the membrane by making a cavity in the center of the membrane, and even if there are marks on the bottom of the well, it can be directly inserted into the microplate absorbance reader for measurement. In addition, the membrane is lifted up by injection of cleaning solution, reaction solution, or sample, and the solution sufficiently spreads to the back side of the membrane, making it possible to perform measurements with less variation.In other words, the membrane can be removed during cleaning and measurement. Since there is no need for this, the operating time is greatly reduced, and there is no difference in measurement values regardless of the presence or absence of a membrane, and accurate measurements can be made, providing superior enzyme immunotherapy compared to conventional methods. It can be said that it is a measurement method.
特に、特別な取り出し操作を必要としないことから、自
動的な測定において非常に有用な方法である。In particular, it is a very useful method for automatic measurements because it does not require any special extraction operation.
次に実施例を挙げて、本発明を更に詳しく Jlt明す
る。Next, the present invention will be explained in more detail with reference to Examples.
〈実施例1〉
酵素免疫法によるアレルゲンの検出
たんばく質を共有結合させられる機能を有する膜(イモ
ピロン−ミリポア リミテッドu S A )を、表面
を汚すことなくマイクロプレートウェルの底面と相似形
にa所し、四に中央部を切り抜いて空洞にする。<Example 1> Detection of allergens by enzyme immunoassay A membrane (Imopilone-Millipore Ltd. USA), which has the function of covalently bonding proteins, was placed in a similar shape to the bottom of a microplate well without contaminating the surface. Place it in place and cut out the center part to make a hollow.
この中央部が空洞になっている収をダニ抽出アレルゲン
水溶液に浸し、膜にアレルゲンを結合させる。The membrane, which has a hollow center, is immersed in an aqueous mite-extracted allergen solution to bind the allergen to the membrane.
このダニアレルゲン結合膜をマイクロプレートのウェル
に装填する(膜はウェルの底にある)。Load this mite allergen-binding membrane into the wells of a microplate (the membrane is at the bottom of the well).
このウェルにダニアレルギー罹患患者血清50μmを入
れ室温で1時間数;δする。50 μm of serum from a patient suffering from mite allergy was placed in this well and allowed to stand at room temperature for 1 hour.
次に、注入した血清を吸引し、洗浄緩衝液で膜及びウェ
ル内を数回洗浄して水切りする。Next, the injected serum is aspirated, and the membrane and the inside of the well are washed several times with a washing buffer and drained.
アルカリ性ホスファターゼ(ALP)を標識した抗ヒト
IgE抗体100μmをウェルに注入し室温で1時間放
置する。100 μm of anti-human IgE antibody labeled with alkaline phosphatase (ALP) is injected into the well and left at room temperature for 1 hour.
21人した抗体液を吸引し、洗浄緩衝液で収及びウェル
内を数回洗浄して水切りする。21 Aspirate the antibody solution, collect with washing buffer, wash the inside of the well several times, and drain.
次にA 1.、 Pの基質である■】−二トロフェノー
ルリン酸溶液100μlを注入し、室温ド正確に30分
後反応停止液200μmを加えてマイクロプレート吸光
度読取装置で計測する。Next A1. Inject 100 μl of ditrophenol phosphoric acid solution, which is a substrate for P, and leave it at room temperature for exactly 30 minutes. Add 200 μl of a reaction stop solution and measure the absorbance using a microplate absorbance reader.
〈実施@2〉
二社のプレートリーダを用い、マイクロプレートのウェ
ル中の膜担体の有無による吸光度測定の影響を調べ、そ
の結果を表1に示す。<Execution @ 2> Using plate readers from two companies, the influence of the presence or absence of a membrane carrier in the wells of the microplate on absorbance measurement was investigated, and the results are shown in Table 1.
〈表L > (405nm○、 D、 (+IT)表
1かられかるように、膜(ディスク)の有無による測定
値に差はなかった。 また、二社の分光器で分光光学的
測定への妨害等の問題はなかった。<Table L> (405 nm○, D, (+IT) As seen from Table 1, there was no difference in the measured values depending on the presence or absence of the film (disk). There were no problems with interference.
〈実施例3〉
痕に種々のアレルゲンエキスを結合させ、希釈倍率を変
化させた場合の影響を調べ、その結果を図1に示す。<Example 3> Various allergen extracts were bound to the scars, and the effects of varying the dilution ratio were investigated, and the results are shown in FIG.
図1において、横軸は、希釈倍率を、縦軸は、吸光度を
表しアレルゲンエキスとしては、卵白、カンジダ、杉花
粉、ダニ、ハウスダストを用い。In FIG. 1, the horizontal axis represents the dilution ratio, and the vertical axis represents the absorbance. Egg white, candida, cedar pollen, mites, and house dust were used as allergen extracts.
それぞれ 、−〇−1−x−5−・− 一ロー、−+−で示す。respectively, −〇−1−x−5−・− One row, indicated by -+-.
Ui4tから明らかなように1種々の希釈倍率において
、アレルゲンエキスのウェルに膜担体があっても1分光
光学的に正確に測定され、洗浄等の操作には問題なく、
更に、血清で希釈して反応系にかけても、その希釈H(
f、練性が保たれていることから、測定の定性性は非常
に優れている。As is clear from Ui4t, even if there is a membrane carrier in the allergen extract well at various dilution ratios, it can be accurately measured spectrophotometrically, and there is no problem with operations such as washing.
Furthermore, even if diluted with serum and applied to the reaction system, the dilution H (
f. Since the kneading property is maintained, the qualitative properties of the measurement are very excellent.
第1図は、膜に種々のアレルゲンエキスを結合させ、希
釈倍率を変化させた場合の副室における影響を示す図で
、横軸は、希釈倍数を、縦軸は、吸光度を表し、そして
、−0−、−x−、−・−1−ロー、−+−は、それぞ
れ卵白、カンジダ、杉花粉、ダニ、ハウスダス1−の各
アレルゲンを表す。
手 続 補 正 3 (方式)昭和63年
8月25日FIG. 1 is a diagram showing the effect on the subchamber when various allergen extracts are bound to the membrane and the dilution ratio is changed. The horizontal axis represents the dilution ratio, the vertical axis represents the absorbance, and -0-, -x-, -.-1-rho, and -+- represent the allergens of egg white, candida, cedar pollen, mites, and house dust 1-, respectively. Procedure Amendment 3 (Method) 1986
August 25th
Claims (2)
て、マイクロプレートのウェルに、抗原または抗体が固
定され中央部が空洞となっている膜を入れ、光学装置に
よって検体濃度を測定する方法。(1) In enzyme immunoassay using a microplate, a membrane with an antigen or antibody immobilized thereon and a hollow center is placed in a well of a microplate, and the sample concentration is measured using an optical device.
ることを特徴とする請求項1記載の測定法。(2) The measuring method according to claim 1, characterized in that an allergen (allergy-causing substance) is immobilized on the membrane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10321788A JPH01274066A (en) | 1988-04-26 | 1988-04-26 | Enzyme immunoassay method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10321788A JPH01274066A (en) | 1988-04-26 | 1988-04-26 | Enzyme immunoassay method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01274066A true JPH01274066A (en) | 1989-11-01 |
Family
ID=14348334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10321788A Pending JPH01274066A (en) | 1988-04-26 | 1988-04-26 | Enzyme immunoassay method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01274066A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0434657U (en) * | 1990-07-20 | 1992-03-23 | ||
US9857367B2 (en) | 2009-07-29 | 2018-01-02 | Dynex Technologies, Inc. | Sample plate systems and methods |
US10207268B2 (en) | 2009-07-29 | 2019-02-19 | Dynex Technologies, Inc. | Sample plate systems and methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53130422A (en) * | 1977-01-14 | 1978-11-14 | Suovaniemi Finnpipette | Forming fragment for apparatus using immune test and enzymatic reaction |
-
1988
- 1988-04-26 JP JP10321788A patent/JPH01274066A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53130422A (en) * | 1977-01-14 | 1978-11-14 | Suovaniemi Finnpipette | Forming fragment for apparatus using immune test and enzymatic reaction |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0434657U (en) * | 1990-07-20 | 1992-03-23 | ||
US9857367B2 (en) | 2009-07-29 | 2018-01-02 | Dynex Technologies, Inc. | Sample plate systems and methods |
US10207268B2 (en) | 2009-07-29 | 2019-02-19 | Dynex Technologies, Inc. | Sample plate systems and methods |
US10969386B2 (en) | 2009-07-29 | 2021-04-06 | Dynex Technologies, Inc. | Sample plate systems and methods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10415104B2 (en) | Devices for the detection of multiple analytes in a sample | |
CN1161611C (en) | Biosensor | |
FI91565C (en) | Method and apparatus for immunoassays | |
CN100492010C (en) | Biosensor | |
US5236826A (en) | Immunoassay for the detection or quantitation of an analyte | |
US4912034A (en) | Immunoassay test device and method | |
US4639419A (en) | Immunological color change test involving two differently colored reagent spots | |
EP0480497B1 (en) | Device for performing a rapid single manual assay | |
JPH01502526A (en) | Immunoassay elements complete with everything you need | |
US5250412A (en) | Swab device and method for collecting and analyzing a sample | |
WO1987003690A1 (en) | Particle-bound binding component immunoassay | |
US4769216A (en) | Device for detecting antigens and antibodies | |
US4590157A (en) | Method for detecting antigens and antibodies | |
US6309893B1 (en) | Assay method with improved release of soluble reagents | |
JP2007526993A (en) | Particle aggregation detection method and apparatus | |
WO1994002850A1 (en) | Transparent assay test devices and methods | |
JPWO2009136476A1 (en) | Biosensor manufacturing method and biosensor | |
TW494238B (en) | Chromatographic test pieces and chromatographic assay | |
JP4068148B2 (en) | Assay method | |
WO2019124532A1 (en) | Immunochromatography device | |
JPS63210664A (en) | Dry test piece for device using oxygen demand detection system and detecting method of analytic component in fluid to be inspected | |
JPS63210772A (en) | Dry test piece and detecting method of analytic component in fluid to be inspected using said test piece | |
JPH01274066A (en) | Enzyme immunoassay method | |
JPH05126832A (en) | Immune analyzer and immune analysis method | |
CN206330984U (en) | A kind of preoperative four measurement systems of full-automatic fluorescent immune method |